Vir Biotechnology (NasdaqGS:VIR) 2025 Conference Transcript

Vir Biotechnology (NasdaqGS:VIR) 2025 Conference November 18, 2025 09:00 AM ET Speaker0Good afternoon, everyone. Thank you for joining Jefferies Healthcare Conference 2025 edition. I'm very happy to have Marianne De Backer with us, CEO of Vir Biotechnology. Thank you.Speaker1Thank you, Juliette. Hello and good afternoon, everyone. Thank you, Jefferies, for the opportunity to provide the latest update on Vir Biotechnology and the rapid progress we are making across our pipeline. I will be making forward-look ...